Our 140,000SF Suzhou center has a strong focus on the clinical innovation in the cardiovascular, ophthalmology and respiratory sector. Together with our Proxima VC which has already 2 RMB fund and 1 USD fund, our Suzhou center has set up the 3rd RMB fund of 70million. Our Suzhou center started its services from June 2021 and currently has 20+ portfolio companies.